ストックスクリーナーアプリを入手
3.80
4.11%
0.15
前日終値:
$3.65
開ける：
$3.67
24時間の取引高:
181.50K
Relative Volume:
2.44
時価総額：
$253.77M
収益：
-
当期純損益:
$-27.63M
株価収益率:
-9.50
EPS:
-0.4
ネットキャッシュフロー:
$-39.43M
1週間 パフォーマンス:
-6.40%
1か月 パフォーマンス:
+22.58%
6か月 パフォーマンス:
+72.74%
1年 パフォーマンス:
+13.43%
1日の値動き範囲:
$3.50
$3.81
1週間の範囲:
$3.50
$4.3866
52週間の値動き範囲:
$1.75
$4.3866
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
DRTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
3.80 | 253.77M | 0 | -27.63M | -39.43M | -0.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-15 | 開始されました | Citigroup | Buy |
| 2023-04-24 | 開始されました | H.C. Wainwright | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-04-08 | 開始されました | Piper Sandler | Overweight |
| 2022-04-04 | 開始されました | Citigroup | Buy |
Alpha Tau Medical Ltd (DRTS) 最新ニュース
Alpha Emitter Market Projected To Witness Massive Growth, - openPR
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day - GlobeNewswire
Alpha Tau Medical Reports Promising Interim Data and Regulatory Milestones in Cancer Trials - TipRanks
Alpha Tau shares interim data across multiple clinical trials at R&D Update Day - TipRanks
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials -January 27, 2025 at 09:02 am EST - Marketscreener.com
Alpha Tau's Cancer Therapy Shows Breakthrough Results in Multiple Clinical Trials - StockTitan
Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Up 14.3% – Still a Buy? - Defense World
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Rises By 7.1% - MarketBeat
Takeout news crowns JPM’s winning stocks - BioCentury
DRTS Stock Touches 52-Week High at $3.43 Amid Sector Growth - Investing.com
DRTS Stock Touches 52-Week High at $3.43 Amid Sector Growth By Investing.com - Investing.com South Africa
US Penny Stocks To Consider In January 2025 - Simply Wall St
Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Up 14.3% – Should You Buy? - Defense World
Alpha Tau to Present Groundbreaking Cancer Therapy Data at ASCO Symposium - TipRanks
Alpha Tau Announces Upcoming Presentation of New Data at - GlobeNewswire
Alpha Tau Medical to Unveil Groundbreaking Cancer Therapy Data at ASCO GI Symposium - StockTitan
Alpha Tau Medical Ltd. Announces Board Changes - Marketscreener.com
Comparing Integra LifeSciences (NASDAQ:IART) and Alpha Tau Medical (NASDAQ:DRTS) - Defense World
Alpha Tau Medical (NASDAQ:DRTS) Stock Price Up 1% – Should You Buy? - Defense World
Alpha Tau Medical Announces Board Leadership Changes Amid Strategic Expansion - TipRanks
Alpha Tau Medical Ltd. Announces Key Shareholder Decisions at Annual Meeting - TipRanks
Alpha Tau Announces Appointment of Maya Netser to its Board - GlobeNewswire
Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor - Quantisnow
Alpha Tau Medical (NASDAQ:DRTS) Trading Up 1%Should You Buy? - MarketBeat
Alpha Emitter Market Set to Witness Steady Growth through (2024-2031) - WhaTech
Alpha Tau to Present at J.P. Morgan Healthcare Conference - TipRanks
DRTSAlpha Tau Medical Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com
Alpha Tau Medical to Present Cancer Therapy Breakthroughs at J.P. Morgan Healthcare Conference - StockTitan
Alpha Tau to Showcase Innovations at Oncology Symposium - TipRanks
Alpha Tau to Participate in Ladenburg's Oncology Innovators & Investors Symposium - The Manila Times
Alpha Tau Medical : to Participate in Ladenburg’s Oncology Innovators & Investors Symposium Form 6 K - Marketscreener.com
Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium - Marketscreener.com
Alpha Tau Medical to Present Alpha DaRT Cancer Therapy at Ladenburg Oncology Symposium - StockTitan
3 Promising Penny Stocks In The US With Market Caps Under $400M - Simply Wall St
Nyxoah (NASDAQ:NYXH) vs. Alpha Tau Medical (NASDAQ:DRTS) Head to Head Contrast - Defense World
Alpha Tau Medical Reports Q3 2024 Financial Results - TipRanks
HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Piper Sandler reaffirms OW rating on Alpha Tau Medical shares as 'multiple milestones' line up - Investing.com South Africa
Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Alpha Tau Medical Advances in Cancer Treatment Technology - TipRanks
Alpha Tau Medical Advances Cancer Treatment Pipeline, Reports $68.4M Cash Position | DRTS Stock News - StockTitan
Alpha Emitter Market Size Expected to Hit USD 1751.5 Million by 2032, Expanding at a 11.25% CAGR: VMR - EIN News
DRTSWAlpha Tau Medical Ltd. Warrant Latest Stock News & Market Updates - StockTitan
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Significant Growth in Short Interest - MarketBeat
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Grows By 30.5% - Defense World
Alpha Tau Medical to Showcase at Key Healthcare Conferences - TipRanks
Alpha Tau Medical Ltd (DRTS) 財務データ
収益
当期純利益
現金流量
EPS
5.49%
0.79%
大文字化:
|
ボリューム (24 時間):